Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by remarkable toxicity and great variability in response to treatment. Plenteous pharmacogenetic studies have already been published for classical therapies, such as cytarabine or anthracyclines, but such studies remain scarce for...

Full description

Bibliographic Details
Main Authors: Álvaro Pinto-Merino, Jorge Labrador, Pablo Zubiaur, Raquel Alcaraz, María José Herrero, Pau Montesinos, Francisco Abad-Santos, Miriam Saiz-Rodríguez
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceutics
Subjects:
acute myeloid leukemia
pharmacogenetics
cytarabine
anthracyclines
FLT3 inhibitors
IDH inhibitors
Online Access:https://www.mdpi.com/1999-4923/14/3/559

Internet

https://www.mdpi.com/1999-4923/14/3/559

Similar Items